EXEL-0862, a novel tyrosine kinase inhibitor, induces apoptosis in vitro and ex vivo in human mast cells expressing the KIT D816V mutation.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples